Keefe Bruyette & Woods raises Marsh & McLennan stock target to USD 201
Published on 10/27/2026 at 17:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and market position
- Keefe, Bruyette & Woods raised its Marsh & McLennan target from USD 186.00 to USD 201.00 on October 19, 2026.
- The company reported third-quarter revenue of USD 6.86 billion for the period ended September 30, 2026.
- Marsh & McLennan stock costs EUR 170.25 at Lang & Schwarz on October 27, 2026 at 5:32 p.m. CEST, 2.07 percent below the Xetra close of October 26, 2026.
- The NYSE quote was USD 189.70 on October 27, 2026, against a 52-week range of USD 156.60 to USD 200.33.
Marsh & McLennan (ISIN US5717481023) stock is facing a lower valuation bar after Keefe, Bruyette & Woods raised its price target from USD 186.00 to USD 201.00 on October 19, 2026, while keeping a Market Perform rating, as reported by MarketBeat. At Lang & Schwarz, the stock was trading at EUR 170.25 on October 27, 2026 at 5:32 p.m. CEST, down 2.07 percent versus the Xetra close of October 26, 2026 at EUR 173.85.
Target leaves a measured upside case
The new USD 201.00 target is 5.96 percent above the USD 189.70 NYSE quote from October 27, 2026. That distance is narrower than the gap created by the earlier USD 186.00 target, which was 1.95 percent below the same market price.
The broader analyst picture remains restrained. MarketBeat reported on October 25, 2026 that 21 research firms carried a consensus Hold rating and an average target of USD 204.42. That average stands 7.76 percent above the USD 189.70 NYSE quote.
Revenue growth meets a softer share price
Marsh reported third-quarter 2026 revenue of USD 6.86 billion, up 8.00 percent from USD 6.35 billion in the third quarter of 2025. Operating income reached USD 1.22 billion, up 4.00 percent, while adjusted earnings per share rose 10.00 percent to USD 2.03. These figures came from the company announcement carried by Financial Times.
Price position and valuation
The NYSE quote was USD 189.70 at 12:33 p.m. ET on October 27, 2026. It sat 5.31 percent below the 52-week high of USD 200.33 and 21.16 percent above the 52-week low of USD 156.60. Trading volume was 597,269 shares, while the market capitalization stood at USD 90.5 billion.
Marsh & McLennan operates across risk, reinsurance and capital, people and investments, and management consulting. Its website describes operations in 130 countries and more than 95,000 colleagues, while the company retained its NYSE listing under the MRSH ticker after its January 2026 brand transition.
What the target means for valuation
The analyst revision places the stock between a recent quarterly growth story and a market price below the new target. The third-quarter revenue increase of 8.00 percent exceeded the 4.00 percent rise in operating income, leaving investors to weigh expansion against the valuation implied by a USD 22.69 billion difference between the target and the current market capitalization.
Stock price after the Xetra close
The euro quotation was EUR 170.25 at Lang & Schwarz on October 27, 2026 at 5:32 p.m. CEST, 2.07 percent below the Xetra close of October 26, 2026 at EUR 173.85.
The further course of trading is shown by the continuously updated real-time quote of Marsh & McLennan stock.
Marsh & McLennan stock facts
- Company: Marsh & McLennan Companies, Inc.
- ISIN: US5717481023
- Ticker: MRSH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 27, 2026, 5:32 p.m. CEST): EUR 170.25
- Change versus Xetra close: minus 2.07 percent
- Xetra close (October 26, 2026): EUR 173.85
- Market capitalization: USD 90.5 billion (as of October 27, 2026)
- 52-week range: USD 156.60-USD 200.33 (as of October 27, 2026)
- Sector / Industry: Financial Services / Insurance Brokers
- Index membership: S&P 500
Market context: Market report S&P 500.
